Background-Some of the prominent features of silicosis are hyperplasia and hypertrophy of epithelial type II cells, which in experimental animals are often accompanied by accumulation of phospholipids in the lung. Methods-The total phospholipid content of lung lavage fluid and its composition in 28 granite stone cutters with long term exposure to silica dust (23 with radiological silicosis) was compared with that of lavage fluid in 15 normal volunteers, 15 patients with untreated idiopathic pulmonary fibrosis, and 19 patients with untreated stage 2 or 3 sarcoidosis. AUl lavage fluid was obtained at the time of first pulmonary investigation, which also included lung function tests. Results-In the normal subjects total
(0. 20) juglml composition being in the range reported in humans. In the patients with silicosis total phospholipid content was significantly decreased to an average of 0-46 (0.08) ,uglml compared with the findings in normal subjects and patients with sarcoidosis. Within the group exposed to silica changes in total phospholipid content did not correlate with the severity of the radiographic disease, changes in lung function, the cellularity of lung lavage fluid, or hyaluronate concentrations. The secretory capacity of rat epithelial type II cells was not significantly different when cultured with bronchoalveolar lavage fluid from all four groups of subjects. Conclusions-Total phospholipid content in lung lavage fluid was significantly reduced in granite workers with radiological evidence of lung disease, but showed no correlation with radiological or functional markers of disease severity. (Thorax 1993; 48:840-844) Reductions in the amount and composition of surface active materials in alveolar lining fluids have been observed in the adult respiratory distress syndrome' and idiopathic pulmonary fibrosis.23 These observations contrast with results in animals with experimental acute lung injury-for example, with silica4 '-in which the total phospholipid content of bronchoalveolar lavage fluid is usually increased.
In humans the accumulation of phospholipids in the lung is part of the repair process following silica inhalation,67 being found in the acute form of silicoproteinosis or in the nodular form of the disease8 associated with increased numbers of epithelial type II cells in the lavage fluid. 9 Other aspects of silicosis in humans have been studied. Subclinical alveolitis has been reported in granite workers, characterised by excessive accumulation of lymphocytes and immunoglobulins and associated with normal phagocytic function and viability of dust laden alveolar macrophages.' 0I The subclinical alveolitis was associated with inhibitory activity of lung lavage fluid against fibroblast proliferation, but fluid from patients with the alveolitis of simple or confluent silicosis upregulated the growth of fibroblasts."2 We have documented a direct proliferative action of silica on type II cells"3 and observed a proliferative activity for type II cells in the bronchoalveolar lavage fluid from normal human lung.'4 This activity was further upregulated early in the silicotic process'4 in contrast to the fibrosing activity, which is increased only after clinical disease is detected. 12 We measured the phospholipid content of lung lavage fluid in humans exposed to silica, comparing the findings with those in normal subjects and patients with idiopathic pulmonary fibrosis or sarcoidosis and correlating the findings with functional markers of severity of disease. We also tested a possible mechanism for the regulation of the accumulation of phospholipids in lavage fluid and evaluated the capacity of fluid from controls and patients with idiopathic pulmonary fibrosis to induce the secretion of phospholipids and proliferation of type II rat epithelial cells.
Methods

PATIENTS
The 15 normal subjects were paid volunteers who were free of symptoms and disease. The 15 patients with idiopathic pulmonary fibrosis and the 19 15 In silicosis we observed significant decreases in the total phospholipid content of lavage fluid, which contrasts with results in animal experiments.45 Several factors can explain these differences. Firstly, the animal models will clearly always be imperfect as type, mode, and intensity of exposure, work environment, and biological substratum can only be approximated.7 Secondly, in sheep the high concentrations of phospholipids in lavage fluid are at least partially sustained by the biologically active silica particles in the bronchoalveolar milieu2'25; the reduction over time of the active dust load25 may contribute to the reduction of phospholipid accumulation. Finally, our patients with radiographic silicosis had been retired for several months before this study, which would also contribute to the reduction in the phospholipid concentration of the bronchoalveolar fluid.
To explain the reduction in the phospholipid content in bronchoalveolar lavage fluid of our patients with silicosis possible mechanisms of regulation of the levels of phospholipids in the bronchoalveolar milieu were investigated. Firstly, we hypothesised that there may be a defect in type II cell secretion induced by the disease process and evaluated the effects of the lavage fluid of these patients on the epithelial type II cell secretion, which was unchanged by the bronchoalveolar lavage fluid from the other groups. Secondly, we observed an increased proliferation capacity of the lavage fluid from the patients with silicosis for epithelial type II cells,'4 which may explain the comparative hypertrophy and hyperplasia of type II cells in silicosis but not the low values of phospholipid in the silicosis groups.
Alternative mechanisms for the reduced phospholipids in bronchoalveolar lavage fluid could be related to altered rates of degradation, clearance, or translocation of the phospholipids in the fluid. Whereas altered clearance or translocation cannot currently be verified properly from the methods, they have some support. Firstly, silica particles in the bronchoalveolar milieu are known to be translocated rapidly to the interstitial space.26 Secondly, phospholipids act as contact inhibitors against the toxicity of silica27 and could also interact with immune complexes in the bronchoalveolar fluid of patients with idiopathic pulmonary fibrosis28 and be translocated rapidly in the interstitial space. Thirdly, the presence of "foreign" material in the alveolar space may accelerate the rate of clearance of these materials29 and associated lipids. Fourthly, within the whole lung the phospholipids accumulated by the disease process associated with silica exposure are known to be deposited largely (in association or not with the silica particles) in the silicotic nodules,8 which may accelerate the translocation of the phospholipids in bronchoalveolar lavage fluid to these sites. Finally, the lipid and protein components of surfactant have multiple roles,30 particularly in the repair process, protecting against the potentially damaging effects of proteases and oxidants released in chronic inflammatory states.
Clearly, the changes in phospholipids in bronchoalveolar lavage fluid that are associated with disease are the result of complex multifaceted inflammation-damage-repair processes.
In conclusion, we have confirmed the low values of phospholipids of surfactant in lung lavage fluid in patients with idiopathic pulmonary fibrosis and documented the absence of influence of the fluid on the secretion and proliferation of epithelial type II cells. In patients with silicosis we found depressed concentrations of phospholipids of surfactant and the absence of changes in type II cell secretion capacity. These changes are inherent to the inflammation-damage-repair process.
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